PDI, a provider of commercialization services to the biopharmaceutical industry has signed an agreement with a major pharmaceutical company for a new contract sales engagement.
Subscribe to our email newsletter
The initiative will utilize PDI’s exclusive Select Access Team to reach pediatricians. The fee-for-service contract, commencing January 2008, is expected to generate approximately $7.5 million in revenue for PDI over its 12-month term.
Michael Marquard, PDI’s CEO, said: “Today’s marketplace demands significant flexibility and the selection of PDI showcases the importance of our sales services offerings to the industry. We are excited at the prospect of delivering exceptional results through exclusive promotion to pediatricians and look forward to a mutually successful endeavor.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.